EMEA-001256-PIP02-12-M02
Key facts
Active substance |
|
Therapeutic area |
Ophthalmology
|
Decision number |
P/0362/2018
|
PIP number |
EMEA-001256-PIP02-12-M02
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Lens therapeutic procedures
|
Route(s) of administration |
|
Contact for public enquiries |
Omeros Corporation
E-mail: swhitaker@omeros.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|